BioSpace News Archive

Cutaneous T-cell lymphoma leads to rash-like skin redness, slightly raised or scaly round patches on the skin, and, sometimes, skin tumors.

Epilepsy is categorized as a chronic disease of the brain and continues to affect millions of individuals across the world

VALBIOTIS, a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces its participation in the prestigious ‘J.P. Morgan Healthcare’ annual conference, taking place from 11 to 14 January 2021, in virtual format.

MorphoSys AG, a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday January 13 at 2:50 p.m. EST.

DuraGraft is a one-time intraoperative treatment used during vascular surgery to reduce the incidence of complications associated with graft failure

Provides EDIT-301 updates, including timeline for dosing sickle cell disease patients in the Phase 1/2 RUBY trial and plans to file IND for the treatment of beta-thalassemia

NeuBase Therapeutics, Inc., a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, announced that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview during the H.C. Wainwright Virtual BioConnect Conference, which is being held from January 11 - 14, 2021.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that it anticipates reported and organic revenue growth of approximately 66% and 63%, respectively, GAAP earnings per share from continuing operations of at least $2.88, and adjusted earnings per share from continuing operations of at least $3.60 for the fourth quarter ended January 3, 2021.

HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that Sebastien St. Louis, Chief Executive Officer, and Trent MacDonald, Chief Financial Officer, will present at the 2021 Annual ICR Conference on Wednesday, January 13, 2021 at 3:30 p.m. ET.

Announces strategic collaborations with Biogen, Genentech to develop RNAi therapeutics for neurodegenerative diseases